Luxembourg vs New Zealand: Share of people with HIV who receive antiretroviral therapy
Luxembourg
84.0%
in 2024
New Zealand
84.0%
in 2024
Luxembourg rank
41st
New Zealand rank
41st
Share of people with HIV who receive antiretroviral therapy over time
- Luxembourg
- New Zealand
How they compare
Luxembourg currently reports 84.0% against 84.0% in New Zealand, a difference of 0.0%.
The two have swapped places 11 times across 25 shared years of data; in 2000 it was Luxembourg ahead.
Luxembourg ranks 41st and New Zealand ranks 41st of 143 countries.
Across the 3 decades both report, Luxembourg averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Luxembourg | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.7% | 43.1% | 1.6% | Luxembourg |
| 2010s | 63.6% | 64.1% | 0.5% | New Zealand |
| 2020s | 79.2% | 79.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Luxembourg or New Zealand?
- Luxembourg, at 84.0% against 84.0% in New Zealand as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Luxembourg and New Zealand?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and New Zealand?
- 25 years are reported by both, from 2000 to 2024.
- How do Luxembourg and New Zealand rank globally for share of people with hiv who receive antiretroviral therapy?
- Luxembourg ranks 41st and New Zealand ranks 41st of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.